Related Experiment Video
Updated: Feb 23, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
Nutrition in Chronic Liver Disease
Marco Silva1, Sara Gomes2, Armando Peixoto1
1Gastroenterology Department, Centro Hospitalar São João, Porto, Portugal.
Proper nutrition is vital for chronic liver disease patients. Early identification and supplementation of nutrient deficiencies, alongside individualized diets, help prevent complications and manage hepatic encephalopathy.
Area of Science:
- Hepatology
- Clinical Nutrition
Background:
- Protein-calorie malnutrition is prevalent in all stages of chronic liver disease.
- Nutritional deficiencies can increase complication risks in liver patients.
Purpose of the Study:
- To emphasize the importance of early nutritional assessment and intervention in chronic liver disease.
- To guide dietary management strategies for patients with chronic liver disease, including those with hepatic encephalopathy.
Main Methods:
- Review of current literature on nutritional management in chronic liver disease.
- Analysis of dietary recommendations and their impact on patient outcomes.
Main Results:
- Early recognition of micro/macronutrient deficiencies is crucial.
- Nutritional supplements can mitigate complications.
- Individualized dietary approaches are superior to restrictive diets.
- Most patients with Grade I/II hepatic encephalopathy tolerate regular diets.
- Protein restriction is generally not advised, except in specific refractory cases.
Conclusions:
- Adequate protein and caloric intake, alongside correction of nutrient deficiencies, are key to managing chronic liver disease.
- Nutritional support should be tailored to individual patient needs.
- Avoidance of unnecessary dietary restrictions is recommended.
More Related Videos
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Chronic Pancreatitis II: Collaborative Care
Assessment: